Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Giordano Bruno who wrote (68439)	9/2/2007 8:52:29 PM
From: ballsschweaty	Read Replies (1) \| Respond to of 116555

<<You have no idea how many cures are currently available if not for drug lobbyist influence on the FDA.>> I've been a biotech investor for years and took a massive position in Dendreon before their advisory panel earlier this year. The advisory panel voted in favor of Provenge, a cancer vaccine for Prostate cancer but the FDA denied approval. Fortunately I tripled my money and then sold it all when I saw the CEO dump 20% of shares prior to the FDA meeting. I invested in Dendreon because I knew for a fact that the vaccine worked and yet it was denied approval. While it should have been approved, the treatment cost $60,000 and only extended life an average of 4 months. Want to know what's a lot more effective than Provenge? Broccoli and daily orgasms have been scientifically proven to prevent Prostate cancer. I don't know about you but I'd rather eat veggies and nail my wife than to get Prostate cancer and spend $60 grand for an extra 4 months of suffering.